AbbVie Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
AbbVie Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • AbbVie Inc. Return On Equity for the quarter ending June 30, 2024 was 57.1 %, a 2.16% decline year-over-year.
  • AbbVie Inc. annual Return On Equity for 2023 was 39.9 %, a 45.8% decline from 2022.
  • AbbVie Inc. annual Return On Equity for 2022 was 73.6 %, a 11.8% decline from 2021.
  • AbbVie Inc. annual Return On Equity for 2021 was 83.4 %, a 61.3% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 39.9 -33.7 -45.8% Jan 1, 2023 Dec 31, 2023
2022 73.6 -9.81 -11.8% Jan 1, 2022 Dec 31, 2022
2021 83.4 +31.7 +61.3% Jan 1, 2021 Dec 31, 2021
2020 51.7 +148 Jan 1, 2020 Dec 31, 2020
2019 -96.2 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.